GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (NAS:PROF) » Definitions » Equity-to-Asset
中文

Profound Medical (Profound Medical) Equity-to-Asset : 0.71 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Profound Medical Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Profound Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $31.18 Mil. Profound Medical's Total Assets for the quarter that ended in Dec. 2023 was $43.91 Mil. Therefore, Profound Medical's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.71.

The historical rank and industry rank for Profound Medical's Equity-to-Asset or its related term are showing as below:

PROF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.48   Med: 0.68   Max: 0.93
Current: 0.71

During the past 10 years, the highest Equity to Asset Ratio of Profound Medical was 0.93. The lowest was 0.48. And the median was 0.68.

PROF's Equity-to-Asset is ranked better than
58.97% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs PROF: 0.71

Profound Medical Equity-to-Asset Historical Data

The historical data trend for Profound Medical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical Equity-to-Asset Chart

Profound Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.93 0.93 0.81 0.71

Profound Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.80 0.78 0.76 0.71

Competitive Comparison of Profound Medical's Equity-to-Asset

For the Medical Devices subindustry, Profound Medical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Profound Medical's Equity-to-Asset falls into.



Profound Medical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Profound Medical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=31.18/43.911
=0.71

Profound Medical's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=31.18/43.911
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Profound Medical  (NAS:PROF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Profound Medical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Profound Medical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Profound Medical (Profound Medical) Business Description

Traded in Other Exchanges
Address
2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.